跳至主要内容
临床试验/EUCTR2013-002027-42-ES
EUCTR2013-002027-42-ES进行中(未招募)1 期

PROSPECTIVE AND RANDOMIZED STUDY FOR ASSESSMENT OF CONTROLLED OVARIAN STIMULATION WITH ALFA Corifollitropin IN PATIENTS WITH OVARIAN RESPONSE EXPECTED OR POOR IN VITRO FERTILIZATION CYCLE.

INSTITUTO DE INVESTIGACION SANITARIA LA FE0 个研究点开始时间: 2013年7月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Patients ? 18 years of age.
  • - Patients who have previously signed consent to participate in this study.
  • - Quen pacietnes submit one of the following factors:
  • 1. Have a history of medical or surgical treatment as a risk factor for POR.
  • 2. Have had a poor ovarian response in response to the EOC (previous cycle after conventional stimulation with ? 3 oocytes)
  • 3. Are poor ovarian response wait to have abnormal ovarian reserve test: AMH <1.1 ng / ml (<8 pM) or RFA <7
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 232
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Anovulation.
  • - Patient with tubal factor, untreated
  • - Patient with uterine pathology, untreated.
  • - Couples with severe male factor, fresh count <5 million / ml, and azoospermia in which sperm are used of the patient, epididymal or testicular.
  • - Patients with BMI> 28.

研究者

发起方
INSTITUTO DE INVESTIGACION SANITARIA LA FE

相似试验